申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2021239885A1
公开(公告)日:2021-12-02
The invention relates to novel compounds for use as inhibitors of NLRP3 inflammasone production, wherein such compounds are as defined by compounds of formula (I) and wherein the integers R1, R2 and R3 are defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of a disease or disorder that is associated with NLRP3 inflammasome activity.
本发明涉及用于抑制NLRP3炎症体产生的新化合物,其中所述化合物由公式(I)定义,其中整数R1、R2和R3在描述中定义,且所述化合物可用作药物,例如用于治疗与NLRP3炎症体活性相关的一种疾病或失调。